From the 17th to the 20th, Bluepharma was represented by Sérgio Simões (Vice President) at DCAT Week 2025 in New York. Bluepharma had the opportunity to establish new strategic partnerships, showcase our differentiated portfolio for licensing, and highlight our integrated development and manufacturing offering, including our expansion into sterile products with a new GMP facility dedicated to complex injectables.